Dexone 4
Drug - Dexone 4
The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Dexamethasone
Multiple ingredients are in alphabetical order.
Strength -
4MG
The potency of the active ingredient(s), Dexamethasone. May repeat for multiple part products.
Applicant -
SOLVAY
The firm name holding legal responsibility for Dexone 4. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
084992
The FDA assigned number to Dexone 4. Format is nnnnnn.
Product Number -
001
The FDA assigned number to identify Dexone 4. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Approved Prior to Jan 1, 1982
The date Dexone 4 was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
No
The pioneer or innovator of Dexone 4. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
DISCN
The group or category of approved drugs Dexone 4 is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Solvay Pharmaceuticals
The full name of the firm holding legal responsibility for the new application of Dexone 4.
Dexone 4
|
